|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
4 May 2015 |
|
Main ID: |
NCT02372812 |
|
Date of registration:
|
20/02/2015 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Analgesic Effects Of Dexamethasone; Its Use To Reduce Post Operative Pain Scores
DOPP |
|
Scientific title:
|
Analgesic Effects Of Dexamethasone; Its Use To Reduce Post Operative Pain Scores: A Double Blinded Randomised Controlled Clinical Trial |
|
Date of first enrolment:
|
July 2014 |
|
Target sample size:
|
173 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT02372812 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Supportive Care
|
|
Phase:
|
Phase 2
|
|
|
Countries of recruitment
|
|
Uganda
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- • Patients scheduled for mastectomies, laparotomies and thyroidectomies that have
given informed consent to participate.
- ASA I & II, patients that have none or have mild to moderate systemic illness.
- Adult patients, above 18 years old.
Exclusion Criteria:
- • Patients with Cushing's disease or Cushing's syndrome
- Patients with diabetes mellitus
- Systemic infection
- Previous history of TB infection
Age minimum:
18 Years
Age maximum:
70 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Pain
|
|
Intervention(s)
|
|
Drug: dexamethasone
|
|
Drug: Placebo
|
|
Primary Outcome(s)
|
|
Post- operative pain scores of the patients using the numerical rating scale, that grades pain from 1-10. The patients will have this scale explained to them. This will be done 24 hours following administration of intraoperative dexamethasone.
[Time Frame: 1 year]
|
|
Secondary Outcome(s)
|
|
: Adverse effects of the dexamethasone
[Time Frame: 1 year]
|
|
Secondary ID(s)
|
|
206000541
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|